4
Changes in Ownership
Gain Therapeutics, Inc. Filed Acc 0001415889-22-005317
CHIEF FINANCIAL OFFICER bought 3,000 shares at $8,100.00 ($24,300,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Calabrese Salvatore CHIEF FINANCIAL OFFICER | 2022-05-19 | Purchase | +3,000 | $8,100.00 | $24,300,000 | D | |
| Open-market purchases · 3,000 sh · avg $8,100.00 · $24,300,000 | |||||||
Loading xslF345X03/form4-05192022_050501.xml…